MannKind | Passività Correnti



Current Liabilities Cambiamento Data
Adma Biologics USD 55.54M 10.65M 2024-12
Dynavax Technologies USD 78.63M 8.6M 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Insmed USD 297.53M 38.34M 2024-12
MacroGenics USD 55.53M 3.78M 2024-12
MannKind USD 81.84M 9.74M 2024-12
Merck USD 28.42B 1.17B 2024-12
Novo Nordisk DKK 208.36B 20.45B 2024-09
Pfizer USD 43B 216M 2024-12
Sanofi 32.22B 3.06B 2025-03
Xencor USD 87.43M 4.54M 2024-12



MannKind Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.